Home / Inspections / 969785

FDA Inspection 969785 — Raritan Pharmaceuticals, Inc.

Raritan Pharmaceuticals, Inc. — FEI 3004083931

The FDA completed an inspection of Raritan Pharmaceuticals, Inc. on April 14, 2016 in East Brunswick, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 14, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
East Brunswick, NJ (United States)

Facility

Other inspections at this facility

  • 1250227 (OAI Wed Apr 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1037112 (VAI Mon Jan 08 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 995165 (OAI Thu Oct 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 799355 (VAI Wed Sep 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 798953 (VAI Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources